COVID-19 PREPAREDNESS AND RESPONSE PLAN Prepared: May 22, 2020
Jeffrey R. Saunders, P.C./Saunders Financial, LLC COVID-19 Preparedness and Response Plan
In accordance with Executive Order 2020-59, Jeffrey R. Saunders, P.C./Saunders Financial, LLC (“Company”) institutes this COVID-19 Preparedness and Response Plan (“Plan”) which is on file and available for members and clients.
Jeffrey R. Saunders is hereby designated as the person responsible for implementing, monitoring, and reporting on COVID-19 control strategies, including training members as to workplace infection control practices and the proper use of personal protective equipment (PPE).
Company is continually monitoring guidance from local, state, and federal health officials and implementing workplace and Plan modifications where appropriate.
1. Prevention Efforts and Workplace Controls
a. Cleanliness and Social Distancing
Members of Jeffrey R. Saunders, P.C./Saunders Financial, LLC will whenever feasible, perform their essential duties remotely.
Company provides members with, at a minimum, non-medical grade face coverings.
In addition, Company is instituting the following cleanliness measures:
• Performing routine environmental cleaning and disinfection of workspaces;
• Requesting that the landlord disinfect all common areas frequently and regularly; and
• Where available, providing hand sanitizer.
Members will minimize COVID-19 exposure by:
• Frequently washing hands with soap and water for at least 20 seconds;
• Utilizing hand sanitizer when soap and water are unavailable;
• Avoiding touching their face with unwashed hands;
• Avoiding handshakes or other physical contact;
• Avoiding all contact with sick people;
• Practicing respiratory etiquette, including covering coughs and sneezes;
• Seeking medical attention and/or following medical advice if experiencing COVID-19 symptoms; and
• Complying with self-isolation or quarantine orders.
b. Supplemental Measures Upon Notification of COVID-19 Diagnosis and/or Symptoms
A member with a COVID-19 diagnosis or who displays symptoms consistent with COVID-19 will self-isolate for at least 14 days and until symptoms are resolved.
c. Member’s Self-Monitoring
Members will not report to the office work site if they:
• Display COVID-19 symptoms, such as fever, cough, shortness of breath, sore throat, new loss of smell or taste, and/or gastrointestinal problems, including nausea, diarrhea, and vomiting, whether or not accompanied by a formal COVID-19 diagnosis;
• In the last 14 days, have had close contact with and/or live with any person having a confirmed COVID-19 diagnosis; and
• Who, in the last 14 days, have had close contact with and/or live with any person displaying COVID-19 symptoms, such as fever, cough, shortness of breath, sore throat, new loss of smell or taste, and/or gastrointestinal problems, including nausea, diarrhea, and vomiting.
Such members may only resume in-person work upon meeting all return-to-work requirements, defined below.
d. Return-to-Work Requirements
Members who were themselves diagnosed with COVID-19 may only return to work upon confirmation of the cessation of symptoms and contagiousness, proof of which may be acquired via the test-based strategy or the non-test-based strategy.
The test-based strategy is preferred but relies upon the availability of testing supplies and laboratory capacity. Under this strategy, members may discontinue isolation and return to work upon achieving the following conditions:
• Resolution of fever without the use of fever-reducing medications;
• Improvement in respiratory symptoms (e.g., cough, shortness of breath); and
• Negative results of an FDA Emergency Use Authorized molecular assay for COVID-19 from two consecutive nasopharyngeal swab specimens collected at least 24 hours apart.
Under the non-test-based strategy, members may discontinue isolation and return to work upon achieving the following conditions:
• At least 3 days (72 hours) have passed since recovery defined as resolution of fever without the use of fever-reducing medications;
• Improvement in respiratory symptoms (e.g., cough, shortness of breath); and
• At least 7 days have passed since symptoms first appeared.
Members who came into close contact with, or live with, an individual with a confirmed diagnosis or symptoms may return to work after either 14 days have passed since the last close contact with the diagnosed/symptomatic individual, or the diagnosed/symptomatic individual receives a negative COVID-19 test.
2. Conduct of Office Meetings
When working on-site at the physical office, Company abides by the recommended social distancing and other safety measures and establishes the following:
• All meetings will be limited to six persons maximum;
• Everyone is required to maintain physical distance no less than six feet apart; and,
• Everyone is required to wear a non-medical grade face covering.
3. Plan Updates and Expiration
This Plan responds to the COVID-19 outbreak. As this pandemic progresses, Company will update this Plan and its corresponding processes.
This Plan will expire upon conclusion of its need, as determined by Company and in accordance with guidance from local, state, and federal health officials.
